What Is 5 Hiaa? Normal vs Optimal Range Explained

Most laboratories report 5-HIAA with a reference range as broad as 0.5–8.0 mmol/mol creatinine, but that wide window hides real dysfunction. A value of 0.7 might technically land inside the normal band, yet it signals that serotonin production is running well below the level associated with stable mood, sound sleep, and healthy gut motility. Roughly 90 percent of the body's serotonin is manufactured in enterochromaffin cells lining the gastrointestinal tract, so a low 5-HIAA value often reflects gut-level production failure before central nervous system effects become apparent. The CTD (Comparative Toxicogenomics Database) maps 847 gene–chemical interactions for serotonin pathway compounds, confirming that even modest downshifts in serotonin metabolites correlate with disrupted tryptophan-to-serotonin conversion and impaired intestinal motility regulation. When your 5-HIAA sits below 1 mmol/mol creatinine, cofactors like iron, vitamin B6, folate, and tetrahydrobiopterin (BH4) deserve investigation because each one gates a different enzymatic step in the serotonin synthesis chain.

On the high end, a 5-HIAA reading above 5 mmol/mol creatinine suggests your body is churning through serotonin faster than expected. The most common driver is overactive monoamine oxidase A (MAOA), the enzyme that breaks serotonin into 5-HIAA. Genetic polymorphisms in the MAOA promoter region can increase enzyme activity by 30–40 percent, accelerating serotonin degradation even without medication involvement. PubMed indexes over 3,200 publications linking elevated urinary 5-HIAA to clinical outcomes ranging from carcinoid syndrome to SSRI-induced serotonin excess. Markedly high values—typically above 15 mmol/mol creatinine—warrant immediate evaluation for neuroendocrine tumors, since carcinoid tumors can flood the bloodstream with serotonin and push 5-HIAA to five or ten times the upper reference limit. For values in the 5–10 range, medication review is the first practical step because several common drug classes—including SSRIs, triptans, and certain opioid analgesics—shift this marker upward through distinct pharmacological mechanisms.

Targeting the 1–5 mmol/mol creatinine sweet spot means your serotonin cycle is balanced: you produce enough of the neurotransmitter to support mood regulation, appetite signaling, and sleep architecture, and you break it down at a pace that prevents accumulation. Maintaining this balance depends on adequate intake of tryptophan-rich protein sources, sufficient cofactor availability, and a controlled inflammatory load across both the gut and the central nervous system. Chronic inflammation is one overlooked variable—when the immune system activates the kynurenine pathway, tryptophan gets diverted away from serotonin and into kynurenine metabolites instead, dropping 5-HIAA without any nutrient deficiency at all. The CTD identifies 23 cytokine-mediated pathways that directly suppress serotonin synthesis through this tryptophan-diversion mechanism. That is why interpreting this marker always requires context from related tests like plasma tryptophan, vitamin B6, and inflammatory markers such as hs-CRP. A single snapshot tells part of the story; pairing it with cofactor levels tells the rest.